Citation Impact
Citing Papers
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
2003 Standout
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID)
2011
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
2015 Standout
Roles of Cardiac Transcription Factors in Cardiac Hypertrophy
2003
Signaling from β1- and β2-adrenergic receptors is defined by differential interactions with PDE4
2008 StandoutNobel
Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 Degradation
2002
Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart
2002
The wnt-frizzled cascade in cardiovascular disease
2002
Protein Kinase A and G Protein-coupled Receptor Kinase Phosphorylation Mediates β-1 Adrenergic Receptor Endocytosis through Different Pathways
2003 StandoutNobel
Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy
2004 Standout
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
Interference of antihypertrophic molecules and signaling pathways with the Ca2+?calcineurin?NFAT cascade in cardiac myocytes
2004
Regulation of the nuclear export of the transcription factor NFATc1 by protein kinases after slow fibre type electrical stimulation of adult mouse skeletal muscle fibres
2006
Cancer chemoprevention with dietary phytochemicals
2003 Standout
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
2001 Standout
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
2006 StandoutNature
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
2006 Standout
Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1
2007 StandoutNobel
Genetic manipulation of myocardial ?-adrenergic receptor activation and desensitization
2004
Calcium signalling: dynamics, homeostasis and remodelling
2003 Standout
NFAT Signaling
2002
Subtype-specific β-adrenoceptor signaling pathways in the heart and their potential clinical implications
2004
Prospects for Cardiovascular Research
2001 StandoutNobel
Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca2+ release channel
2007 StandoutNobel
Fas receptor signaling inhibits glycogen synthase kinase 3β and induces cardiac hypertrophy following pressure overload
2002
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
2002 Standout
Protein kinase cascades in the regulation of cardiac hypertrophy
2005
WNT and β-catenin signalling: diseases and therapies
2004 Standout
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
2002 Standout
Transcriptional regulation by calcium, calcineurin, and NFAT
2003 Standout
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
2010
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
2005 Standout
Cardiac autophagy is a maladaptive response to hemodynamic stress
2007 Standout
Glycogen Synthase Kinase 3β Regulates GATA4 in Cardiac Myocytes
2001
Calcineurin and cardiac hypertrophy: Where have we been? Where are we going?
2002
Calcium–calcineurin signaling in the regulation of cardiac hypertrophy
2004
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Deletion of cytosolic phospholipase A2 promotes striated muscle growth
2003
Erythropoietin protects cardiac myocytes against anthracycline-induced apoptosis
2007
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
2003 Standout
Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2
2007 StandoutNobel
A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function
2006 StandoutNature
p21 in cancer: intricate networks and multiple activities
2009 Standout
The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase
2005 StandoutNobel
Cardiorenal Syndrome
2008 Standout
The Third Intracellular Loop and the Carboxyl Terminus of β2-Adrenergic Receptor Confer Spontaneous Activity of the Receptor
2003 StandoutNobel
Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy
2004
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
2002 Standout
Dose-dependent Blockade to Cardiomyocyte Hypertrophy by Histone Deacetylase Inhibitors
2003
Regulation of Angiogenesis by Glycogen Synthase Kinase-3β
2002
Toward transcriptional therapies for the failing heart: chemical screens to modulate genes
2005
Glycogen Synthase Kinase-3β Regulates Growth, Calcium Homeostasis, and Diastolic Function in the Heart
2004
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
Protein Kinase A Negatively Modulates the Nuclear Accumulation of NF-ATc1 by Priming for Subsequent Phosphorylation by Glycogen Synthase Kinase-3
2002
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Calcineurin?NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs
2004
Agonist-dependent Recruitment of Phosphoinositide 3-Kinase to the Membrane by β-Adrenergic Receptor Kinase 1
2001
Regulation of cardiac hypertrophy by intracellular signalling pathways
2006 Standout
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Expression of Constitutively Active Guanylate Cyclase in Cardiomyocytes Inhibits the Hypertrophic Effects of Isoproterenol and Aortic Constriction on Mouse Hearts
2003
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease
2004
Melusin, a muscle-specific integrin β1–interacting protein, is required to prevent cardiac failure in response to chronic pressure overload
2002
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Adrenomedullin Gene Delivery Protects Against Cerebral Ischemic Injury by Promoting Astrocyte Migration and Survival
2004
The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
2004 Standout
In Vivo Ventricular Gene Delivery of a β-Adrenergic Receptor Kinase Inhibitor to the Failing Heart Reverses Cardiac Dysfunction
2001 StandoutNobel
PTEN Activity Is Modulated During Ischemia and Reperfusion
2005 StandoutNobel
Hypertrophy of the Heart
2004
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice
2003
Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes
2006 StandoutNobel
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Judging a Protein by More Than Its Name: GSK-3
2001
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier
2012 StandoutNobel
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
2002
Glycogen Synthase Kinase-3β
2002
Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes
2002
Conditional Deletion of Focal Adhesion Kinase Leads to Defects in Ventricular Septation and Outflow Tract Alignment
2007 StandoutNobel
Targeted Disruption of NFATc3, but Not NFATc4, Reveals an Intrinsic Defect in Calcineurin-Mediated Cardiac Hypertrophic Growth
2002
Direct and Indirect Interactions between Calcineurin-NFAT and MEK1-Extracellular Signal-Regulated Kinase 1/2 Signaling Pathways Regulate Cardiac Gene Expression and Cellular Growth
2005
Control of Cardiac Growth by Histone Acetylation/Deacetylation
2006
Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice
2002
On the pivotal role of PPARa in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury
2016 StandoutNobel
Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure
2000
Trafficking of G Protein–Coupled Receptors
2006 StandoutNobel
Myocardial AKT: The Omnipresent Nexus
2011
Dysregulation of the TSC-mTOR pathway in human disease
2004 Standout
Fas receptor signaling inhibits glycogen synthase kinase 3β and induces cardiac hypertrophy following pressure overload
2002
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity
2007
Level of β-Adrenergic Receptor Kinase 1 Inhibition Determines Degree of Cardiac Dysfunction After Chronic Pressure Overload–Induced Heart Failure
2005 StandoutNobel
Organization of β-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes
2007 StandoutNobel
Pulmonary artery smooth muscle hypertrophy: roles of glycogen synthase kinase-3β and p70 ribosomal S6 kinase
2010
Specific β 2 AR Blocker ICI 118,551 Actively Decreases Contraction Through a G i -Coupled Form of the β 2 AR in Myocytes From Failing Human Heart
2002
Works of Hardeep Ranu being referenced
The effect of Gi‐protein inactivation on basal, and β1‐ and β2AR‐stimulated contraction of myocytes from transgenic mice overexpressing the β2‐adrenoceptor
2000
SERCA2a Overexpression Decreases the Incidence of Aftercontractions in Adult Rabbit Ventricular Myocytes
2001
Functional alterations in adult rat myocytes after overexpression of phospholamban with use of adenovirus
1999
Gi-dependent suppression of β1-adrenoceptor effects in ventricular myocytes from NE-treated guinea pigs
2000
Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
2000